The present disclosure is directed to reconstructing and/or generating a corrected planar scintigraphy image (CPSI) corrected for (e.g., without or with reduced), image artifacts based on a plurality of planar scintigraphy images.
The following description of the background of the present technology is provided simply as an aid in understanding the present technology and is not admitted to describe or constitute prior art to the present technology.
Certain nuclear medical imaging methods, such as scintigraphy, can be used for imaging a bio-distribution of a molecular target by using radiotracers and gamma ray detectors. A pair of opposing gamma ray detectors (e.g., equipped with parallel-hole lead or tungsten collimators) can be used to obtain one or more medical images of a subject. The obtained medical images may contain image noise and image artifacts. Certain techniques, such as post-filtering the medical images, can reduce the image noise at the expense of spatial resolution. However, said techniques are insufficient in removing the aforementioned image artifacts from the medical images.
This Summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This Summary is not intended to identify key features or essential features, nor is it intended to limit the scope of the claims included herewith.
The present disclosure is directed towards systems and methods for generating and/or reconstructing a CPSI (or other medical images) with certain image artifacts reduced or eliminated (e.g., artifacts caused by gamma ray attenuation, gamma ray collimator penetration, gamma ray scatter, and/or other processes) by using (or according to) a plurality of planar scintigraphy images. The systems and methods, for instance, can be based on a planar scintigraphy image reconstruction model/approach for generating a CPSI according to an anterior planar scintigraphy image or a posterior planar scintigraphy image (e.g., an anterior/posterior (A/P) image pair (conjugate views)). The planar scintigraphy image reconstruction model can be based on a physical model of a two-view single photon emission computed tomography (SPECT) system, in which the physical properties of a plurality of gamma ray detectors (or other types of detectors) are considered (e.g., to reconstruct a planar projection, such as the CPSI).
In one aspect, the present disclosure is directed to a computing system for generating and/or reconstructing a CPSI corrected for image artifacts (e.g., caused by gamma ray attenuation, gamma ray collimator penetration, gamma ray scatter, and/or other processes) based on (or according to) a plurality of planar scintigraphy images. The system may comprise one or more processors and a non-transitory computer-readable medium having instructions stored thereon. The one or more processors can execute the instructions stored on the non-transitory computer-readable medium. Upon execution of the instructions by the one or more processors, the instructions may cause the system to obtain a plurality of planar scintigraphy images of a subject. The plurality of planar scintigraphy images may contain/include image artifacts caused by one or more physical processes. The instructions may cause the system to generate, by the one or more processors, a CPSI corrected for (e.g., without) the image artifacts by applying a planar scintigraphy image reconstruction model to the plurality of planar scintigraphy images. The planar scintigraphy image reconstruction model may comprise a non-negativity constraint. The planar scintigraphy image reconstruction model can be based on a regularization term and a fidelity term. The instructions may cause the system to present, by the one or more processors, the CPSI for evaluation of a condition of the subject. Presenting the CPSI may comprise at least one of transmitting the CPSI to a computing device or displaying the CPSI on a display screen.
In some embodiments, the plurality of planar scintigraphy images may comprise an anterior planar scintigraphy image or a posterior planar scintigraphy image. In certain embodiments, the one or more physical processes may comprise gamma ray attenuation, gamma ray collimator penetration, or gamma ray scatter. In some embodiments, obtaining the plurality of planar scintigraphy images may comprise using a plurality of gamma ray detectors to generate the plurality of planar scintigraphy images. In certain embodiments, the regularization term may correspond to a total variation regularization for controlling noise. In some embodiments, the regularization term may correspond to (or be associated with) other types of regularization approaches for controlling noise (e.g., tight framelets based on a redundant multiscale discrete cosine transform, deep learning approaches, and/or other types of approaches for controlling noise). In certain examples, the regularization term may include or correspond to other types of regularization for controlling noise, such as deep learning, sparse representation, quadratic, and/or other types. In some embodiments, the planar scintigraphy image reconstruction model may comprise a minimization operation based on the regularization term, the fidelity term, and the non-negativity constraint. The minimization operation can be based on a divergence norm and a regularization parameter (λ).
In some embodiments, the planar scintigraphy image reconstruction model may be based on a two-view single photon emission computed tomography (SPECT) physical model. The two-view SPECT physical model may comprise an anterior view and a posterior view. In certain embodiments, generating the CPSI may comprise estimating an anterior/posterior (A/P) projection of activity bio-distribution using the two-view SPECT physical model as a constraint. The two-view SPECT physical model may be determined according to ∫J
wherein a resolution loss is dependent of y3 and invariant in the y1,2 plane, and a Gaussian blur with a variance of σx2(y3) is used. In certain embodiments, applying the planar scintigraphy image reconstruction model may comprise determining
wherein the
Applying the planar scintigraphy image reconstruction model may comprise determining
wherein the
∥Kƒ−g∥KL=Kƒ−g log (Kƒ), wherein the B3 denotes or corresponds to a three dimensional first order gradient block matrix. In some embodiments, the instructions may further cause the computing system to apply or solve the discretized planar scintigraphy image reconstruction model using a fixed point algorithm with higher order total variation regularization (HOTV) according to:
wherein the b denotes (or corresponds to) a first subgradient term, the c denotes (or corresponds to) a second subgradient term, the C3 denotes (or corresponds to) a three dimensional second order gradient block matrix, the φ1 denotes (or corresponds to) a first order isotropic total variation norm, the φ2 denotes (or corresponds to) a second order isotropic total variation norm, the λ1 denotes (or corresponds to) a first regularization parameter, the λ2 denotes (or corresponds to) a second regularization parameter, the S denotes (or corresponds to) a preconditioner, the ρ1 denotes (or corresponds to) a first algorithmic parameter, and the ρ2 denotes (or corresponds to) a second algorithmic parameter. In some embodiments, the instructions may further cause the computing system to apply or solve the discretized planar scintigraphy image reconstruction model using other approaches, such as alternating direction method of multipliers (ADMM), Chambolle-Pock, and/or other approaches.
In one aspect, the present disclosure is directed to a method for generating and/or reconstructing a CPSI corrected for (e.g., without) image artifacts (e.g., caused by gamma ray attenuation, gamma ray collimator penetration, gamma ray scatter, and/or other processes) based on (or according to) a plurality of planar scintigraphy images. A computing system may obtain a plurality of planar scintigraphy images of a subject. The plurality of planar scintigraphy images may contain image artifacts caused by one or more physical processes. The computing system may generate a CPSI corrected for (e.g., without) the image artifacts by applying a planar scintigraphy image reconstruction model to the plurality of planar scintigraphy images. The planar scintigraphy image reconstruction model may comprise a non-negativity constraint. The planar scintigraphy image reconstruction model may be based on a regularization term and a fidelity term. The computing system may present the CPSI for evaluation of a condition of the subject. Presenting the CPSI may comprise at least one of transmitting the CPSI to a computing device or displaying the CPSI on a display screen.
In some embodiments, the plurality of planar scintigraphy images may comprise an anterior planar scintigraphy image or a posterior planar scintigraphy image. In certain embodiments, the one or more physical processes may comprise gamma ray attenuation, gamma ray collimator penetration, or gamma ray scatter. In some embodiments, obtaining the plurality of planar scintigraphy images may comprise using a plurality of gamma ray detectors to generate the plurality of planar scintigraphy images. In certain embodiments, the regularization term may correspond to a total variation regularization for controlling noise. In some embodiments, the regularization term may correspond to (or be associated with) other types of regularization approaches for controlling noise (e.g., tight framelets based on a redundant multiscale discrete cosine transform, deep learning approaches, and/or other types of approaches for controlling noise). In certain examples, the regularization term may include or correspond to other types of regularization for controlling noise, such as deep learning, sparse representation, quadratic, and/or other types. In some embodiments, the planar scintigraphy image reconstruction model may comprise a minimization operation based on the regularization term, the fidelity term, and the non-negativity constraint. The minimization operation can be based on a divergence norm and a regularization parameter (λ). In certain embodiments, the method may include determining, according to the generated CPSI, a dosage of radiation administered to the subject that minimizes a risk of toxicity to non-cancerous tissue, while optimizing treatment for cancerous tissue.
In some embodiments, the planar scintigraphy image reconstruction model may be based on a two-view single photon emission computed tomography (SPECT) physical model. The two-view SPECT physical model may comprise an anterior view and a posterior view. In certain embodiments, generating the CPSI may comprise estimating an anterior/posterior (A/P) projection of activity bio-distribution using the two-view SPECT physical model as a constraint. In some embodiments, the method may include determining the two-view SPECT physical model according to ∫J3 K(x; y)ƒ(y)dy=g(x), x∈J3, wherein x:=(x1, x2, x3), y:=(y1, y2, y3), the g(x) describes the plurality of planar scintigraphy images, the ƒ(y) represents a 3D biodistribution and the K(x; y) describes a kernel of a region J:=[α, b]. In some embodiments, the K(x; y) can be determined according to an attenuation map derived from CT. In some embodiments, the method may include determining the K(x; y) according to K(x; y)=δ(x1−y1, x2−y2)e−
wherein the
Applying the planar scintigraphy image reconstruction model may comprise determining
wherein the
wherein the B3 denotes (or corresponds to) a three dimensional first order gradient block matrix. In some embodiments, the method may include applying or solving the discretized planar scintigraphy image reconstruction model using a fixed point algorithm with higher order total variation regularization (HOTV) according to:
wherein the b denotes (or corresponds to) a first subgradient term, the c denotes (or corresponds to) a second subgradient term, the C3 denotes (or corresponds to) a three dimensional second order gradient block matrix, the φ1 denotes (or corresponds to) a first order isotropic total variation norm, the φ2 denotes (or corresponds to) a second order isotropic total variation norm, the λ1 denotes (or corresponds to) a first regularization parameter, the λ2 denotes (or corresponds to) a second regularization parameter, the S denotes a (or corresponds to) preconditioner, the ρ1 denotes (or corresponds to) a first algorithmic parameter, and the ρ2 denotes (or corresponds to) a second algorithmic parameter. In some embodiments, the method may further comprise using the CPSI to evaluate the condition of the subject.
The foregoing and other objects, aspects, features, and advantages of the disclosure will become more apparent and better understood by referring to the following description taken in conjunction with the accompanying drawings, in which:
For purposes of reading the description of the various embodiments below, the following descriptions of the sections of the specification and their respective contents may be helpful:
Section A describes a network environment and computing environment which may be useful for practicing embodiments described herein.
Section B describes embodiments of systems and methods of the present technology for reconstructing and/or generating a corrected planar scintigraphy image (CPSI) corrected for (e.g., without or with reduced) image artifacts based on a plurality of planar scintigraphy images.
Prior to discussing specific embodiments of the present solution, it may be helpful to describe aspects of the operating environment as well as associated system components (e.g., hardware elements) in connection with the methods and systems described herein. Referring to
Although
The network 104 may be connected via wired or wireless links. Wired links may include Digital Subscriber Line (DSL), coaxial cable lines, or optical fiber lines. The wireless links may include BLUETOOTH, Wi-Fi, Worldwide Interoperability for Microwave Access (WiMAX), an infrared channel or satellite band. The wireless links may also include any cellular network standards used to communicate among mobile devices, including standards that qualify as 1G, 2G, 3G, 4G, or 5G. The network standards may qualify as one or more generation of mobile telecommunication standards by fulfilling a specification or standards such as the specifications maintained by International Telecommunication Union. The 3G standards, for example, may correspond to the International Mobile Telecommunications-2000 (IMT-2000) specification, and the 4G standards may correspond to the International Mobile Telecommunications Advanced (IMT-Advanced) specification. Examples of cellular network standards include AMPS, GSM, GPRS, UMTS, LTE, LTE Advanced, Mobile WiMAX, and WiMAX-Advanced. Cellular network standards may use various channel access methods e.g. FDMA, TDMA, CDMA, or SDMA. In some embodiments, different types of data may be transmitted via different links and standards. In other embodiments, the same types of data may be transmitted via different links and standards.
The network 104 may be any type and/or form of network. The geographical scope of the network 104 may vary widely and the network 104 can be a body area network (BAN), a personal area network (PAN), a local-area network (LAN), e.g. Intranet, a metropolitan area network (MAN), a wide area network (WAN), or the Internet. The topology of the network 104 may be of any form and may include, e.g., any of the following: point-to-point, bus, star, ring, mesh, or tree. The network 104 may be an overlay network which is virtual and sits on top of one or more layers of other networks 104′. The network 104 may be of any such network topology as known to those ordinarily skilled in the art capable of supporting the operations described herein. The network 104 may utilize different techniques and layers or stacks of protocols, including, e.g., the Ethernet protocol, the internet protocol suite (TCP/IP), the ATM (Asynchronous Transfer Mode) technique, the SONET (Synchronous Optical Networking) protocol, or the SDH (Synchronous Digital Hierarchy) protocol. The TCP/IP internet protocol suite may include application layer, transport layer, internet layer (including, e.g., IPv6), or the link layer. The network 104 may be a type of a broadcast network, a telecommunications network, a data communication network, or a computer network.
In some embodiments, the system may include multiple, logically-grouped servers 106. In one of these embodiments, the logical group of servers may be referred to as a server farm 38 or a machine farm 38. In another of these embodiments, the servers 106 may be geographically dispersed. In other embodiments, a machine farm 38 may be administered as a single entity. In still other embodiments, the machine farm 38 includes a plurality of machine farms 38. The servers 106 within each machine farm 38 can be heterogeneous-one or more of the servers 106 or machines 106 can operate according to one type of operating system platform (e.g., WINDOWS NT, manufactured by Microsoft Corp. of Redmond, Washington), while one or more of the other servers 106 can operate on according to another type of operating system platform (e.g., Unix, Linux, or Mac OS X).
In one embodiment, servers 106 in the machine farm 38 may be stored in high-density rack systems, along with associated storage systems, and located in an enterprise data center. In this embodiment, consolidating the servers 106 in this way may improve system manageability, data security, the physical security of the system, and system performance by locating servers 106 and high performance storage systems on localized high performance networks. Centralizing the servers 106 and storage systems and coupling them with advanced system management tools allows more efficient use of server resources.
The servers 106 of each machine farm 38 do not need to be physically proximate to another server 106 in the same machine farm 38. Thus, the group of servers 106 logically grouped as a machine farm 38 may be interconnected using a wide-area network (WAN) connection or a metropolitan-area network (MAN) connection. For example, a machine farm 38 may include servers 106 physically located in different continents or different regions of a continent, country, state, city, campus, or room. Data transmission speeds between servers 106 in the machine farm 38 can be increased if the servers 106 are connected using a local-area network (LAN) connection or some form of direct connection. Additionally, a heterogeneous machine farm 38 may include one or more servers 106 operating according to a type of operating system, while one or more other servers 106 execute one or more types of hypervisors rather than operating systems. In these embodiments, hypervisors may be used to emulate virtual hardware, partition physical hardware, virtualize physical hardware, and execute virtual machines that provide access to computing environments, allowing multiple operating systems to run concurrently on a host computer. Native hypervisors may run directly on the host computer. Hypervisors may include VMware ESX/ESXi, manufactured by VMWare, Inc., of Palo Alto, California; the Xen hypervisor, an open source product whose development is overseen by Citrix Systems, Inc.; the HYPER-V hypervisors provided by Microsoft or others. Hosted hypervisors may run within an operating system on a second software level. Examples of hosted hypervisors may include VMware Workstation and VIRTUALBOX.
Management of the machine farm 38 may be de-centralized. For example, one or more servers 106 may comprise components, subsystems and modules to support one or more management services for the machine farm 38. In one of these embodiments, one or more servers 106 provide functionality for management of dynamic data, including techniques for handling failover, data replication, and increasing the robustness of the machine farm 38. Each server 106 may communicate with a persistent store and, in some embodiments, with a dynamic store.
Server 106 may be a file server, application server, web server, proxy server, appliance, network appliance, gateway, gateway server, virtualization server, deployment server, SSL VPN server, or firewall. In one embodiment, the server 106 may be referred to as a remote machine or a node. In another embodiment, a plurality of nodes 290 may be in the path between any two communicating servers.
Referring to
The cloud 108 may be public, private, or hybrid. Public clouds may include public servers 106 that are maintained by third parties to the clients 102 or the owners of the clients. The servers 106 may be located off-site in remote geographical locations as disclosed above or otherwise. Public clouds may be connected to the servers 106 over a public network. Private clouds may include private servers 106 that are physically maintained by clients 102 or owners of clients. Private clouds may be connected to the servers 106 over a private network 104. Hybrid clouds 108 may include both the private and public networks 104 and servers 106.
The cloud 108 may also include a cloud based delivery, e.g. Software as a Service (SaaS) 110, Platform as a Service (PaaS) 112, and Infrastructure as a Service (IaaS) 114. IaaS may refer to a user renting the use of infrastructure resources that are needed during a specified time period. IaaS providers may offer storage, networking, servers or virtualization resources from large pools, allowing the users to quickly scale up by accessing more resources as needed. Examples of IaaS can include infrastructure and services (e.g., EG-32) provided by OVH HOSTING of Montreal, Quebec, Canada, AMAZON WEB SERVICES provided by Amazon.com, Inc., of Seattle, Washington, RACKSPACE CLOUD provided by Rackspace US, Inc., of San Antonio, Texas, Google Compute Engine provided by Google Inc. of Mountain View, California, or RIGHTSCALE provided by RightScale, Inc., of Santa Barbara, California. PaaS providers may offer functionality provided by IaaS, including, e.g., storage, networking, servers or virtualization, as well as additional resources such as, e.g., the operating system, middleware, or runtime resources. Examples of PaaS include WINDOWS AZURE provided by Microsoft Corporation of Redmond, Washington, Google App Engine provided by Google Inc., and HEROKU provided by Heroku, Inc. of San Francisco, California. SaaS providers may offer the resources that PaaS provides, including storage, networking, servers, virtualization, operating system, middleware, or runtime resources. In some embodiments, SaaS providers may offer additional resources including, e.g., data and application resources. Examples of SaaS include GOOGLE APPS provided by Google Inc., SALESFORCE provided by Salesforce.com Inc. of San Francisco, California, or OFFICE 365 provided by Microsoft Corporation. Examples of SaaS may also include data storage providers, e.g. DROPBOX provided by Dropbox, Inc. of San Francisco, California, Microsoft SKYDRIVE provided by Microsoft Corporation, Google Drive provided by Google Inc., or Apple ICLOUD provided by Apple Inc. of Cupertino, California.
Clients 102 may access IaaS resources with one or more IaaS standards, including, e.g., Amazon Elastic Compute Cloud (EC2), Open Cloud Computing Interface (OCCI), Cloud Infrastructure Management Interface (CIMI), or OpenStack standards. Some IaaS standards may allow clients access to resources over HTTP, and may use Representational State Transfer (REST) protocol or Simple Object Access Protocol (SOAP). Clients 102 may access PaaS resources with different PaaS interfaces. Some PaaS interfaces use HTTP packages, standard Java APIs, JavaMail API, Java Data Objects (JDO), Java Persistence API (JPA), Python APIs, web integration APIs for different programming languages including, e.g., Rack for Ruby, WSGI for Python, or PSGI for Perl, or other APIs that may be built on REST, HTTP, XML, or other protocols. Clients 102 may access SaaS resources through the use of web-based user interfaces, provided by a web browser (e.g. GOOGLE CHROME, Microsoft INTERNET EXPLORER, or Mozilla Firefox provided by Mozilla Foundation of Mountain View, California). Clients 102 may also access SaaS resources through smartphone or tablet applications, including, e.g., Salesforce Sales Cloud, or Google Drive app. Clients 102 may also access SaaS resources through the client operating system, including, e.g., Windows file system for DROPBOX.
In some embodiments, access to IaaS, PaaS, or SaaS resources may be authenticated. For example, a server or authentication server may authenticate a user via security certificates, HTTPS, or API keys. API keys may include various encryption standards such as, e.g., Advanced Encryption Standard (AES). Data resources may be sent over Transport Layer Security (TLS) or Secure Sockets Layer (SSL).
The client 102 and server 106 may be deployed as and/or executed on any type and form of computing device, e.g. a computer, network device or appliance capable of communicating on any type and form of network and performing the operations described herein.
The central processing unit 121 is any logic circuitry that responds to and processes instructions fetched from the main memory unit 122. In many embodiments, the central processing unit 121 is provided by a microprocessor unit, e.g.: those manufactured by Intel Corporation of Mountain View, California; those manufactured by Motorola Corporation of Schaumburg, Illinois; the ARM processor and TEGRA system on a chip (SoC) manufactured by Nvidia of Santa Clara, California; the POWER7 processor, those manufactured by International Business Machines of White Plains, New York; or those manufactured by Advanced Micro Devices of Sunnyvale, California. The computing device 100 may be based on any of these processors, or any other processor capable of operating as described herein. The central processing unit 121 may utilize instruction level parallelism, thread level parallelism, different levels of cache, and multi-core processors. A multi-core processor may include two or more processing units on a single computing component. Examples of multi-core processors include the AMD PHENOM IIX2, INTEL CORE i5 and INTEL CORE i7.
Main memory unit 122 may include one or more memory chips capable of storing data and allowing any storage location to be directly accessed by the microprocessor 121. Main memory unit 122 may be volatile and faster than storage 128 memory. Main memory units 122 may be Dynamic random access memory (DRAM) or any variants, including static random access memory (SRAM), Burst SRAM or SynchBurst SRAM (BSRAM), Fast Page Mode DRAM (FPM DRAM), Enhanced DRAM (EDRAM), Extended Data Output RAM (EDO RAM), Extended Data Output DRAM (EDO DRAM), Burst Extended Data Output DRAM (BEDO DRAM), Single Data Rate Synchronous DRAM (SDR SDRAM), Double Data Rate SDRAM (DDR SDRAM), Direct Rambus DRAM (DRDRAM), or Extreme Data Rate DRAM (XDR DRAM). In some embodiments, the main memory 122 or the storage 128 may be non-volatile; e.g., non-volatile read access memory (NVRAM), flash memory non-volatile static RAM (nvSRAM), Ferroelectric RAM (FeRAM), Magnetoresistive RAM (MRAM), Phase-change memory (PRAM), conductive-bridging RAM (CBRAM), Silicon-Oxide-Nitride-Oxide-Silicon (SONOS), Resistive RAM (RRAM), Racetrack, Nano-RAM (NRAM), or Millipede memory. The main memory 122 may be based on any of the above described memory chips, or any other available memory chips capable of operating as described herein. In the embodiment shown in
A wide variety of I/O devices 130a-130n may be present in the computing device 100. Input devices may include keyboards, mice, trackpads, trackballs, touchpads, touch mice, multi-touch touchpads and touch mice, microphones, multi-array microphones, drawing tablets, cameras, single-lens reflex camera (SLR), digital SLR (DSLR), CMOS sensors, accelerometers, infrared optical sensors, pressure sensors, magnetometer sensors, angular rate sensors, depth sensors, proximity sensors, ambient light sensors, gyroscopic sensors, or other sensors. Output devices may include video displays, graphical displays, speakers, headphones, inkjet printers, laser printers, and 3D printers.
Devices 130a-130n may include a combination of multiple input or output devices, including, e.g., Microsoft KINECT, Nintendo Wiimote for the WII, Nintendo WII U GAMEPAD, or Apple IPHONE. Some devices 130a-130n allow gesture recognition inputs through combining some of the inputs and outputs. Some devices 130a-130n provides for facial recognition which may be utilized as an input for different purposes including authentication and other commands. Some devices 130a-130n provides for voice recognition and inputs, including, e.g., Microsoft KINECT, SIRI for IPHONE by Apple, Google Now or Google Voice Search.
Additional devices 130a-130n have both input and output capabilities, including, e.g., haptic feedback devices, touchscreen displays, or multi-touch displays. Touchscreen, multi-touch displays, touchpads, touch mice, or other touch sensing devices may use different technologies to sense touch, including, e.g., capacitive, surface capacitive, projected capacitive touch (PCT), in-cell capacitive, resistive, infrared, waveguide, dispersive signal touch (DST), in-cell optical, surface acoustic wave (SAW), bending wave touch (BWT), or force-based sensing technologies. Some multi-touch devices may allow two or more contact points with the surface, allowing advanced functionality including, e.g., pinch, spread, rotate, scroll, or other gestures. Some touchscreen devices, including, e.g., Microsoft PIXELSENSE or Multi-Touch Collaboration Wall, may have larger surfaces, such as on a table-top or on a wall, and may also interact with other electronic devices. Some I/O devices 130a-130n, display devices 124a-124n or group of devices may be augment reality devices. The I/O devices may be controlled by an I/O controller 123 as shown in
In some embodiments, display devices 124a-124n may be connected to I/O controller 123. Display devices may include, e.g., liquid crystal displays (LCD), thin film transistor LCD (TFT-LCD), blue phase LCD, electronic papers (e-ink) displays, flexile displays, light emitting diode displays (LED), digital light processing (DLP) displays, liquid crystal on silicon (LCOS) displays, organic light-emitting diode (OLED) displays, active-matrix organic light-emitting diode (AMOLED) displays, liquid crystal laser displays, time-multiplexed optical shutter (TMOS) displays, or 3D displays. Examples of 3D displays may use, e.g. stereoscopy, polarization filters, active shutters, or autostereoscopy. Display devices 124a-124n may also be a head-mounted display (HMD). In some embodiments, display devices 124a-124n or the corresponding I/O controllers 123 may be controlled through or have hardware support for OPENGL or DIRECTX API or other graphics libraries.
In some embodiments, the computing device 100 may include or connect to multiple display devices 124a-124n, which each may be of the same or different type and/or form. As such, any of the I/O devices 130a-130n and/or the I/O controller 123 may include any type and/or form of suitable hardware, software, or combination of hardware and software to support, enable or provide for the connection and use of multiple display devices 124a-124n by the computing device 100. For example, the computing device 100 may include any type and/or form of video adapter, video card, driver, and/or library to interface, communicate, connect or otherwise use the display devices 124a-124n. In one embodiment, a video adapter may include multiple connectors to interface to multiple display devices 124a-124n. In other embodiments, the computing device 100 may include multiple video adapters, with each video adapter connected to one or more of the display devices 124a-124n. In some embodiments, any portion of the operating system of the computing device 100 may be configured for using multiple displays 124a-124n. In other embodiments, one or more of the display devices 124a-124n may be provided by one or more other computing devices 100a or 100b connected to the computing device 100, via the network 104. In some embodiments software may be designed and constructed to use another computer's display device as a second display device 124a for the computing device 100. For example, in one embodiment, an Apple iPad may connect to a computing device 100 and use the display of the device 100 as an additional display screen that may be used as an extended desktop. One ordinarily skilled in the art will recognize and appreciate the various ways and embodiments that a computing device 100 may be configured to have multiple display devices 124a-124n.
Referring again to
Client device 100 may also install software or application from an application distribution platform. Examples of application distribution platforms include the App Store for iOS provided by Apple, Inc., the Mac App Store provided by Apple, Inc., GOOGLE PLAY for Android OS provided by Google Inc., Chrome Webstore for CHROME OS provided by Google Inc., and Amazon Appstore for Android OS and KINDLE FIRE provided by Amazon.com, Inc. An application distribution platform may facilitate installation of software on a client device 102. An application distribution platform may include a repository of applications on a server 106 or a cloud 108, which the clients 102a-102n may access over a network 104. An application distribution platform may include application developed and provided by various developers. A user of a client device 102 may select, purchase and/or download an application via the application distribution platform.
Furthermore, the computing device 100 may include a network interface 118 to interface to the network 104 through a variety of connections including, but not limited to, standard telephone lines LAN or WAN links (e.g., 802.11, T1, T3, Gigabit Ethernet, Infiniband), broadband connections (e.g., ISDN, Frame Relay, ATM, Gigabit Ethernet, Ethernet-over-SONET, ADSL, VDSL, BPON, GPON, fiber optical including FiOS), wireless connections, or some combination of any or all of the above. Connections can be established using a variety of communication protocols (e.g., TCP/IP, Ethernet, ARCNET, SONET, SDH, Fiber Distributed Data Interface (FDDI), IEEE 802.11a/b/g/n/ac CDMA, GSM, WiMax and direct asynchronous connections). In one embodiment, the computing device 100 communicates with other computing devices 100′ via any type and/or form of gateway or tunneling protocol e.g. Secure Socket Layer (SSL) or Transport Layer Security (TLS), or the Citrix Gateway Protocol manufactured by Citrix Systems, Inc. of Ft. Lauderdale, Florida. The network interface 118 may comprise a built-in network adapter, network interface card, PCMCIA network card, EXPRESSCARD network card, card bus network adapter, wireless network adapter, USB network adapter, modem or any other device suitable for interfacing the computing device 100 to any type of network capable of communication and performing the operations described herein.
A computing device 100 of the sort depicted in
The computer system 100 can be any workstation, telephone, desktop computer, laptop or notebook computer, netbook, ULTRABOOK, tablet, server, handheld computer, mobile telephone, smartphone or other portable telecommunications device, media playing device, a gaming system, mobile computing device, or any other type and/or form of computing, telecommunications or media device that is capable of communication. The computer system 100 has sufficient processor power and memory capacity to perform the operations described herein. The computer system 100 can be of any suitable size, such as a standard desktop computer or a Raspberry Pi 4 manufactured by Raspberry Pi Foundation, of Cambridge, United Kingdom. In some embodiments, the computing device 100 may have different processors, operating systems, and input devices consistent with the device. The Samsung GALAXY smartphones, e.g., operate under the control of Android operating system developed by Google, Inc. GALAXY smartphones receive input via a touch interface.
In some embodiments, the computing device 100 is a gaming system. For example, the computer system 100 may comprise a PLAYSTATION 3, or PERSONAL PLAYSTATION PORTABLE (PSP), or a PLAYSTATION VITA device manufactured by the Sony Corporation of Tokyo, Japan, a NINTENDO DS, NINTENDO 3DS, NINTENDO WII, or a NINTENDO WII U device manufactured by Nintendo Co., Ltd., of Kyoto, Japan, an XBOX 360 device manufactured by the Microsoft Corporation of Redmond, Washington.
In some embodiments, the computing device 100 is a digital audio player such as the Apple IPOD, IPOD Touch, and IPOD NANO lines of devices, manufactured by Apple Computer of Cupertino, California. Some digital audio players may have other functionality, including, e.g., a gaming system or any functionality made available by an application from a digital application distribution platform. For example, the IPOD Touch may access the Apple App Store. In some embodiments, the computing device 100 is a portable media player or digital audio player supporting file formats including, but not limited to, MP3, WAV, M4A/AAC, WMA Protected AAC, AIFF, Audible audiobook, Apple Lossless audio file formats and .mov, .m4v, and .mp4 MPEG-4 (H.264/MPEG-4 AVC) video file formats.
In some embodiments, the computing device 100 is a tablet e.g. the IPAD line of devices by Apple; GALAXY TAB family of devices by Samsung; or KINDLE FIRE, by Amazon.com, Inc. of Seattle, Washington. In other embodiments, the computing device 100 is an eBook reader, e.g. the KINDLE family of devices by Amazon.com, or NOOK family of devices by Barnes & Noble, Inc. of New York City, New York.
In some embodiments, the communications device 102 includes a combination of devices, e.g. a smartphone combined with a digital audio player or portable media player. For example, one of these embodiments is a smartphone, e.g. the IPHONE family of smartphones manufactured by Apple, Inc.; a Samsung GALAXY family of smartphones manufactured by Samsung, Inc.; or a Motorola DROID family of smartphones. In yet another embodiment, the communications device 102 is a laptop or desktop computer equipped with a web browser and a microphone and speaker system, e.g. a telephony headset. In these embodiments, the communications devices 102 are web-enabled and can receive and initiate phone calls. In some embodiments, a laptop or desktop computer is also equipped with a webcam or other video capture device that enables video chat and video call.
In some embodiments, the status of one or more machines 102, 106 in the network 104 are monitored, generally as part of network management. In one of these embodiments, the status of a machine may include an identification of load information (e.g., the number of processes on the machine, CPU and memory utilization), of port information (e.g., the number of available communication ports and the port addresses), or of session status (e.g., the duration and type of processes, and whether a process is active or idle). In another of these embodiments, this information may be identified by a plurality of metrics, and the plurality of metrics can be applied at least in part towards decisions in load distribution, network traffic management, and network failure recovery as well as any aspects of operations of the present solution described herein. Aspects of the operating environments and components described above will become apparent in the context of the systems and methods disclosed herein.
In medical imaging applications (e.g., planar scintigraphy imaging and/or other types of medical imaging), radiologists and/or physicians can view/analyze one or more medical images of a subject (e.g., anterior/posterior (A/P) image) for diagnostic and/or treatment purposes. Certain medical image(s), such as planar scintigraphy images, may describe and/or indicate an accumulated count distribution produced by collimated single photon emissions within said subject. Similar to other types of medical images (e.g., reconstructed 3D tomographic images), planar scintigraphy images may contain degradation and/or artifacts caused by one or more physical processes (such as attenuation, scatter, or collimator penetration). The image degradation/artifacts can obscure/obfuscate certain physiological/anatomical information within the planar scintigraphy images, thereby reducing the clinical value and/or usability of the medical images for answering clinical questions.
In some imaging modalities, the use of certain radionuclides (such as radionuclides that emit high energy photons and/or have low counts) may cause an increased amount of imaging artifacts within the planar scintigraphy images (compared to using other types of radionuclides). For instance, radionuclides used in targeted alpha therapy (TAT) can have a low photon yield, long half-lives, and/or a plurality of photon energies (including high-energy photons), which due to radiation dose constraint, can limit the administered TAT activity (e.g., administered to the subject). Further, imaging times may not be sufficiently extended to increase the yield of imageable photons. As a result, planar scintigraphy images can be excessively noisy and contain imaging artifacts. In TAT, alpha emitting molecules can be used to target and/or treat cancerous cells/tissue within a subject. However, for the reasons discussed above, the quality of a TAT planar scintigraphy image may not allow for patient-specific prescriptions of administered TAT activity that optimize treatment of cancerous tissue (e.g., maximize the probability of cure), while minimizing a risk of toxicity to non-cancerous tissue. As such, improving the image quality of planar scintigraphy images (e.g., removing the image artifacts caused by physical processes) can enable image-guided optimization of TAT activity in a subject, thereby allowing for an assessment and/or evaluation of the therapeutic benefits of TAT.
A plurality of approaches have been applied to planar scintigraphy images in an attempt to improve the quality (e.g., removing the image artifacts) of said images, such as denoising by post-filtering via wavelet transformation, Fourier and wavelet transformations, contourlets, bandelets, complex ridgelets, curvelets, blind-deconvolution schemes, statistically adaptive methods, and/or Monte Carlo methods. However, said approaches fail to consider and/or include a physical/system model for planar scintigraphy, and as such, are unable to remove the image artifacts caused by one or more physical processes (e.g., attenuation, scatter, and/or collimator penetration). Furthermore, applying said approaches to the planar scintigraphy images can reduce the spatial resolution of the images.
Embodiments of the systems and methods presented herein include a novel approach for generating and/or reconstructing a CPSI corrected for said image artifacts (e.g., without reducing spatial resolution) by using a plurality of planar scintigraphy images, such as an anterior planar scintigraphy image and a posterior planar scintigraphy image. The disclosed approach is based on a physical model of a two-view SPECT system, in which an anterior planar scintigraphy image may correspond to a posterior planar scintigraphy image upon removal of the image artifacts from the planar scintigraphy images. In certain embodiments, a planar scintigraphy image reconstruction model (based on the two-view SPECT physical model) can be applied to the plurality of planar scintigraphy images to generate the CPSI. The planar scintigraphy image reconstruction model can be based on a novel regularized image reconstruction approach (e.g., based on sparse image representation), in which the two-view SPECT physical model can be used as a constraint for computing and/or estimating a total activity bio-distribution between a plurality of gamma ray detectors (e.g., detectors for generating the plurality of planar scintigraphy images).
Referring to
The computing device 100 (or multiple computing devices) may be used to control and/or receive signals acquired via imaging system 240, emitting system 250, and/or motion sensor 260 directly. In certain implementations, computing system 100 may be used to control and/or receive signals acquired via the planar scintigraphy system 230. For instance, the computing device 100 may receive and/or obtain a plurality of scintigraphy images of a subject (and/or other signals) from the imaging system 240, wherein the gamma ray detectors 245 of the imaging system 240 can be used to obtain/capture the planar scintigraphy images. The computing device 100 may include one or more processors and one or more volatile and non-volatile memories for storing computing code and data that are captured, acquired, recorded, and/or generated (e.g., captured, acquired, recorded and/or generated by the computing device 100 and/or the planar scintigraphy system 230). The computing device 100 may include a controller 212 that is configured to exchange control signals with the planar scintigraphy system 230, imaging system 240, emitting system 250, motion sensor 260, and/or platform 290, allowing the computing device 100 to be used to control the capture of images (e.g., planar scintigraphy images and/or other types of images) and/or signals via the sensors (e.g., gamma ray detectors 245) thereof, and position or reposition the subject. The computing device 100 may also include an image reconstruction engine 214 configured to perform the computations and analyses discussed herein with respect to generating a CPSI. For example, the image reconstruction engine 214 can apply a planar scintigraphy image reconstruction model to a plurality of planar scintigraphy images (e.g., captured, generated, or otherwise obtained via the imaging system 240).
A transceiver 218 allows the computing device 100 to exchange readings, control commands, and/or other data with the planar scintigraphy system 230, the imaging system 240, the emitting system 250, the motion sensor 260, and/or the platform 290 wirelessly or via wires. One or more user interfaces 220 (e.g., I/O devices 130) can allow the computing device 100 to receive user inputs (e.g., via a keyboard, touchscreen, microphone, camera, etc.) and provide outputs (e.g., via a display screen, audio speakers, etc.). For instance, the one or more user interfaces 220 can allow the computing device 100 to present the CPSI for evaluation of a condition of the subject (e.g., via a display 124 of the planar scintigraphy system 230 and/or the computing device 100). The computing device 100 may additionally include one or more databases 222 for storing, for example, signals acquired via one or more sensors, signatures, etc. For example, the database(s) 222 may store and/or maintain the planar scintigraphy images and/or the generated CPSI. In some implementations, database 222 (or portions thereof) may alternatively or additionally be part of another computing device that is co-located or remote and in communication with computing device 100, planar scintigraphy system 230, imaging system 240, emitting system 250, motion sensor 260, and/or platform 290.
Referring to
In brief overview, process 350 can include obtaining a plurality of planar scintigraphy images (352). The process 350 may include generating a corrected planar scintigraphy image (CPSI) (354). The process 350 may include presenting the generated CPSI for evaluation of a condition of a subject (356). The process 350 may include determining a dosage of radiation according to the CPSI (358).
Referring now to operation (352), and in some embodiments, a computing system (e.g., a client 102, a server 106, and/or a computing device 100) may obtain, receive, and/or acquire a plurality of planar scintigraphy images (or other medical images) of a subject. For instance, the computing system may obtain the plurality of planar scintigraphy images by generating and/or capturing said images using a plurality of gamma ray detectors (e.g., gamma ray cameras). In one example, the computing system may obtain the plurality of planar scintigraphy images by receiving (e.g., according to one or more signals) said images from another computing system (e.g., a medical imaging system) and/or computing device 100. The plurality of planar scintigraphy images may contain and/or include image artifacts caused by one or more physical processes. For instance, the plurality of planar scintigraphy images may contain image artifacts caused by gamma ray attenuation, gamma ray collimator penetration, gamma ray scatter, and/or other physical processes. In some embodiments, the plurality of planar scintigraphy images may include/comprise an anterior planar scintigraphy image and/or a posterior planar scintigraphy image. In certain embodiments, the anterior planar scintigraphy image may include or correspond to the posterior planar scintigraphy image upon removal of the image artifacts and/or image noise from said images. Certain processes (such as determining a geometric mean of the plurality of planar scintigraphy images) may remove (e.g., from the planar scintigraphy images) a portion of the image artifacts caused by gamma ray attenuation, but are unable to remove image artifacts caused by gamma ray collimator penetration, gamma ray scatter, and/or other physical processes.
Referring now to operation (354), and in some embodiments, the computing system may generate a CPSI (e.g., based on the plurality of planar scintigraphy images) corrected for (e.g., without) the image artifacts of the plurality of planar scintigraphy images. For instance, the computing system may generate said CPSI by applying a planar scintigraphy image reconstruction model to the plurality of planar scintigraphy images (e.g., processing the plurality of planar scintigraphy images with the planar scintigraphy image reconstruction model). The planar scintigraphy image reconstruction model may comprise a non-negativity constraint (e.g., values equal to or greater than zero) and/or other types of constraints. The planar scintigraphy image reconstruction model can be based on a regularization term and/or a fidelity term. The fidelity term (e.g., a divergence norm and/or other types of norms or semi-norms, such as a L1-norm and/or a KL-norm) can measure, determine, and/or quantify how a first probability distribution (e.g., a probability distribution associated to the plurality of planar scintigraphy images) is different from a second probability distribution (e.g., a probability distribution associated to a model of a two-view SPECT system). In some embodiments, the regularization term may correspond to a total variation (TV) regularization (and/or other types of regularization, such as tight framelets based on a redundant multiscale discrete cosine transform and/or deep learning approaches) for controlling noise (e.g., count noise). In certain examples, the regularization term may include or correspond to other types of regularization for controlling noise, such as deep learning, sparse representation, quadratic, and/or other types.
In some embodiments, the planar scintigraphy image reconstruction model may comprise a minimization operation (e.g., a minimization of a mode) based on the regularization term, the fidelity term, and/or the non-negativity constraint. For instance, the planar scintigraphy image reconstruction model may comprise a minimization of a sum (or other operation(s)) of the regularization term, the fidelity term, and/or the non-negativity constraint (e.g., to estimate and/or generate the CPSI). In some embodiments, the minimization operation can be based on a divergence norm (e.g., a Kullback-Leibler (KL) divergence norm and/or other types of norms) and/or a regularization parameter (λ). For example, the minimization operation can include a minimization of a KL divergence norm (or other norms). In certain embodiments, the regularization parameter may determine a weight of the regularization term within the planar scintigraphy image reconstruction model.
In some embodiments, the planar scintigraphy image reconstruction model may be based on (or correspond to) a two-view single photon emission computed tomography (SPECT) physical model. In one example, the process 300 may include applying or solving the SPECT physical problem/model to generate the CPSI. The two-view SPECT physical model may comprise a conjugate pair of detectors/images, such as an anterior view and a posterior view (e.g., a conjugate anterior/posterior (A/P) pair of images/detectors, a right/left pair of images/detectors, and/or an angle/angle+180 degrees pair of images detectors). In certain embodiments, generating the CPSI may comprise estimating conjugate views, such as an A/P projection of activity bio-distribution (e.g., a bio-distribution of a molecular target, such as a bio-distribution of TAT tracers) using the two-view SPECT physical model as a constraint. In some embodiments, the two-view SPECT physical model can be determined (e.g., determined by the computing system) according to ∫J
In certain embodiments, applying the planar scintigraphy image reconstruction model may comprise determining
The
In some embodiments, the process 300 may include discretizing (e.g., by the computing system) the planar scintigraphy image reconstruction model. The planar scintigraphy image reconstruction model can be discretized according to
The KL-divergence norm can be given by ∥Kf−g|KL=Kf−g log(Kƒ). The B3 may include or correspond to a three dimensional first order gradient block matrix. In certain embodiments, the discretized planar scintigraphy image reconstruction model can be applied or solved via a fixed-point approach and/or other types of approaches, such as ADMM and/or Chambolle-Pock. For instance, the discretized planar scintigraphy image reconstruction model can be applied or solved using a fixed-point algorithm with higher order total variation regularization (HOTV) and/or other types of regularization according to:
In certain embodiments, the b may include or correspond to a first subgradient term, while the c may include or correspond to a second subgradient term. The C3 may describe, include or correspond to a three dimensional second order gradient block matrix. The φ1 may include or correspond to a first order isotropic total variation norm, while the φ2 may include or correspond to a second order isotropic total variation norm. In some embodiments, the λ1 may include or correspond to a first regularization parameter (e.g., a weight of a regularization term), while the λ2 may include or correspond to a second regularization parameter. In certain embodiments, the S may include or correspond to a preconditioner. The ρ1 may include or correspond to a first algorithmic parameter, while the ρ2 may include or correspond to a second algorithmic parameter. The proxl+ may include or correspond to a proximity operator of the indicator function (e.g., for the non-negativity constraint). In some embodiments, the
may include or correspond to a proximity operator of an isotropic total variation norm. In
the {circumflex over (ƒ)} may include or correspond to a converged solution (e.g., {circumflex over (ƒ)}≈ƒk=∞) to the planar scintigraphy image reconstruction model, wherein the Δk describes a voxel spacing. Although the recovery of {circumflex over (ƒ)} represents an ill-posed problem, the mean information in y1/y2 can be recovered by summing along y3.
In certain embodiments, the Moreau envelope function for a convex function ψ: Rn→R can be defined/determined by (or according to)
For B3 and C3, N=√{square root over (d)}. In some embodiments, IN may include or correspond to a N×N identity matrix, while D can describe a N×N backward difference matrix such that Dj,j=1 and Dj,j−1=−1 for j=2,1, . . . N. As such, the other entries of D may include or correspond to zero. Through a matrix Kronecker product ⊗, B3∈R3N and C3∈R9N can be determined and/or described according to:
In some embodiments, the first order isotropic total variation norm φ1 can be defined/determined by (or according to)
In certain embodiments, the second order isotropic total variation norm φ2 can be defined/determined by (or according to)
In certain embodiments, the preconditioner by (or according to) S can be defined by
The algorithmic parameters ρ1,2 can be defined by
wherein
The regularization parameters λ1,2 can be determined according to a mean squared error approach (and/or other approaches).
Referring now to operation (356), and in some embodiments, the computing system may present, display, or otherwise provide the CPSI for evaluation (e.g., evaluation by a clinician) of a condition of the subject. In one example, a clinician may evaluate the CPSI and/or other information to determine a medical condition of the subject. The computing system may present the CPSI by transmitting, sending, and/or communicating the CPSI to a computing device 100 and/or displaying the CPSI on a display screen (e.g., one or more display devices 124a-124n).
Referring now to operation (358), and in some embodiments, the process 300 can include determining a dosage of radiation administered to the subject (e.g., to treat a medical condition) according to the generated CPSI (e.g., to determine a therapeutic benefit and/or a risk of toxicity). For instance, a dose of administered TAT activity (e.g., administered to the subject) can be determined according to the CPSI, wherein the determined dose of administered TAT activity can minimize/reduce a risk of toxicity to non-cancerous tissue while optimizing treatment for cancerous tissue. As such, the generated CPSI (with an improved image quality compared to the plurality of planar scintigraphy images) can enable an assessment and/or evaluation of the therapeutic benefits of TAT for treating a condition of the subject. In some embodiments, the generated CPSI can be used to evaluate a condition of the subject.
The performance of the systems and methods described herein can be evaluated according to (or by using) a numerical phantom with a 3×3 contrast detail object in a uniform background. The numerical phantom, as shown in
Referring to
The following embodiments of the systems and methods discussed herein are demonstrative of features of various alternative example embodiments.
Currently, there is no conventional curative approach for patients with advanced-stage metastatic prostate cancer. Happily, the recent remarkable success of the alpha-emitting radiopharmaceutical (AER) 225Ac-PSMA-617 in the treatment of metastatic castration-resistant prostate cancer (mCRPC) has revealed the striking clinical potential of Targeted Alpha Therapy (TAT).
TAT has been developing rapidly and has been applied as a treatment for many advanced-stage cancers in addition to mCRPC including leukemia, melanoma, bladder cancer, glioma, and neuroendocrine tumors. The two main benefits provided by alpha emitters are: (i) highly selective targeting of cancer cells while avoiding off-target cytotoxicity, due to the short α-particle ranges in tissue (<100 μm, i.e., a few cell diameters); and (ii) enhanced cell killing mediated by DNA double strand breaks and clustered fragmentation, that is largely independent of oxygenation status, cell cycle stage, and dose rate, due to the high linear energy transfer (LET; ˜100 keV/μm) of alpha particles. Currently, aside from 223Ra, the most widely investigated radionuclide for clinical TAT is 225Ac.
Current methods of imaging the biodistribution of AER are sub-optimal, primarily due to limitations on administered activity. This has several related knock-on effects: (i) AER biodistributions are unknown; (ii) absorbed dose distributions for AER are unknown; (iii) the correspondence between AER biodistributions and those of potential imaging surrogates is unknown. Thus, our ability to anticipate normal tissue toxicity and prescribe personalized treatment is compromised. Accurate quantitative imaging of the AER biodistribution can help remedy this situation and advance the field.
There is urgent need to be able to convert the very noisy, low-count scintigraphic images produced from low activities of AER into quantitative images of activity distribution that are adequate for reliable dosimetry estimation. The systems and methods discussed herein include a novel approach to improve quantitative TAT imaging. Current TAT images are of insufficient quality to implement the type of personalized, dosimetry-based therapy that is anticipated to improve patient outcomes. Potential surrogate biomarkers can be valuable if they can be shown to accurately represent the AER biodistribution. However, the degree of correspondence cannot be assessed without improved TAT imaging. The lack of such methods is a barrier to progress; preventing the optimization of personalized TAT and impeding the development of new AER.
The systems and methods described herein include a novel approach for the generation of accurate, corrected planar scintigraphic images of AER (CPSIAER) using low-count AER planar data and co-registered low-dose CT images acquired on SPECT/CT cameras. The obtained CPSIAER combined with CT can permit accurate AER activity estimation that may be used as input data for a dosimetry model, which can provide information on the radiation dose to organs/tumor. The systems and methods described herein can include a novel sparsity promoting reconstruction approach based on a physical model for planar AER imaging. Low-count 225Ac planar images and co-registered low-dose CT images acquired on SPECT/CT cameras, for example, as well as physical and digital phantoms, can be used.
Initial studies performed with simulated data, can show that the sparsity promoting methods can substantially improve quantitative and detective performance of scintigraphic imaging of AER. The novel approach may rely on a physical imaging model containing the system kernels and regularization. To control noise, a sparsity promoting regularization with envelope of the 10-norm can be used. The fixed-point proximity-operator approach (or other approaches) can be used to solve the resulting nonconvex minimization problem. The effects of noise on tumor/organ activity estimates may be accounted for with an ensemble mean squared error performance metric.
As a result of said novel approach, the direct quantitative imaging of AER and optimized personalized design of TAT including improved activity/fractionation schedule may become available. It can lead to higher likelihood of response and cure. It can also enable rational assessment of the utility of imaging AER surrogates.
Alpha-emitting radiopharmaceuticals (AER), such as 225Ac-PSMA-617 in the treatment of metastatic castration-resistant prostate cancer (mCRPC), show the exciting clinical potential of Targeted Alpha Therapy (TAT). TAT can be applied to the treatment of many other advanced-stage cancers including leukemia, melanoma, bladder cancer, glioma, and neuroendocrine tumors. There are two main benefits provided by alpha emitters: (i) The short range of α-particles in the tissue comparable, to a few cell diameters (<100 μm), which allows selective targeted cancer cell killing while avoiding off-target cytotoxicity, in contrast to external-beam radiation therapy or beta emitter-based therapy (e.g. with 90Y, 131I, or 177Lu33), and (ii) The high energy (typically in the 4-9 MeV range) of alpha particles combined with much higher linear energy transfer (LET; 25-230 keV/μm) vs. β-particle (0.1-1 keV/μm) promotes cancer cell killing via DNA double strand breaks and clustered fragmentation, reducing or eliminating the dependence of cytotoxicity on oxygenation status, cell cycle stage, dose rate, and largely overcoming cellular radio-resistance. Currently, aside from 223Ra the most clinically investigated radionuclide for clinical TAT is 225Ac (T1/2=9.9 d, pure α emitter with energies in the 5.8-8.4 MeV, 47-85 μm range in tissue). In most foreseeable circumstances, 225Ac exists in close-to-secular equilibrium with its radioactive progeny including 221Fr (T1/2=4.8 min, pure a emitter with 218 keV γ emission at 11.4% yield) and 213Bi (T1/2=46 min, mixed α/β emitter with 440 keV γ emission at 26.1% yield). 225Ac itself has no significant γ emission and can only be non-invasively imaged using the γ emissions of 221Fr and/or 213Bi. Clinical trials with 225Ac-PSMA-617 or 225Ac-DOTATATE in patients resistant to conventional radionuclide therapies with beta emitters have demonstrated the clinical potential of TAT, with objective responses and mild side effects reported. Clinical studies with 225Ac-labeled SSRT- and PSMA-targeting small molecules are ongoing worldwide.
Because currently AER biodistributions are mostly unknown, the absorbed dose distributions for AER are unknown. Thus, safety (dose to normal tissues/organs) and efficacy (dose to tumor) of AER are difficult to access. Patient selection and some aspects of risk stratification and predictive biodistribution for AER can be accomplished via pretreatment quantitative imaging with single photon or positron-emitting surrogates of AER. For example, 68Ga-PSMA quantitative PET/CT imaging may be performed to select patients for 225Ac-PSMA and for baseline, interval and restaging quantification of the extent of disease. However, the correspondence between AER biodistributions and those of potential imaging surrogates remains unknown and limits the ability to determine optimal AER dose for a specific patient. Further, surrogate imaging is not “real-time” and has to be repeated each time information is needed. It cannot be used to assess off target anomalous distribution (e.g., extravasation, contamination, labeling issues). Direct imaging of AER is desirable but at present provides poor quality images. Thus, the ability to anticipate normal tissue toxicity and prescribe personalized treatment is compromised.
AER are difficult to image, especially those that decay via alpha-emitting progeny (e.g. 225Ac), because only very low activities can be administered (˜100 kBq/kg). This is a consequence of the high radiobiological potency of AER and consequently only low-count gamma camera-based imaging is possible. Current SOC methods produce images that are very noisy and difficult to quantify. Recently, hybrid protocols combining whole-body planar imaging with quantitative abdominal SPECT/CT for 225Ac-PSMA has been reported, but the utility of SPECT for 225Ac remains anecdotal. To ensure that TAT is both effective and safe, in vivo molecular imaging that enables the efficacious verification of AER biodistribution and therapeutic index is necessary. Consequently, there is an urgent unmet need to develop appropriate methods for low-count gamma camera image processing. The absence of such methods represents a barrier to progress in the field of TAT; hindering the personalization of treatment to provide maximum benefit and minimize toxicity and impeding the development of new AERs.
The systems and methods discussed herein can address this unmet need by implementation of a novel regularized model-based approach to reconstruct an accurate corrected planar scintigraphic AER biodistribution image (CPSIAER) and verify its superiority using a task-based image quality (IQ) assessment approach. The proposed model can be based on an anterior-posterior conjugate image pair acquired by a single photon emission computed tomography (SPECT/CT) physical system. It may comprise modeling of the collimator (including septal penetration), spatial and energy resolution, and attenuation and scatter (from the accompanying CT). Noise may be controlled by means of sparsity promoting regularization, which utilizes the envelope of the 10-norm (env-10). A preconditioned fixed-point algorithm (PFA) can be used to solve the resulting nonconvex minimization problem. A task-based methodology is applied for assess IQ assessment.
Because of the extremely low activity of administered AER, too few counts are acquired to generate clinically acceptable whole-body tomographic images. As a result, planar whole-body imaging is performed instead of SPECT. Unfortunately, the planar images are very difficult to quantify and are very noisy. To address these weaknesses, the systems and methods described herein can use accurate image formation models and/or advanced sparsity promoting regularization methods to obtain a CPSIAER from an anterior-posterior conjugate whole-body planar image pair acquired by a SPECT/CT camera, and use co-registered CT data to correct for collimator distance-dependent spatial resolution, scatter, attenuation, and/or collimator-originated artifacts. The resultant higher-quality lower-noise quantitative images of the AER biodistributions combined with CT images of tumors/organs may be suitable for 3D dosimetry studies.
The systems and methods described herein can include a new approach for scintigraphic whole-body planar image processing in TAT. It may allow optimized personalized design of TAT including activity/fractionation schedule leading to higher likelihood of response and cure. It may also enable rational assessment of the utility of imaging surrogates, and is hypothesized to improve the therapeutic ratio of TAT. External co-registered CT can be used with older gamma cameras, not equipped with CT. The proposed systems/methods may not require vendor's support for implementation. Hence, they can be applied to any planar scintigraphic imaging studies.
Various embodiments of the systems and methods discussed here improve the computational properties of the AER imaging model. To control noise, approximate sparsity regularization via the env-10 can be used. In the past, such models were intractable due to 10-norm's discontinuous nature. However, the novel approach discussed herein (env-10) makes the use of 10-norm manageable via an efficient preconditioned fixed-point algorithm. Task-based IQ assessment may be used to evaluate improvement. The systems and methods may use a regularized image reconstruction approach for generating corrected planar images. Said systems and methods may include an implementation of a hybrid planar/CT data acquisition by means of SPECT/CT camera and exploitation of CT data for estimation of 3D dose distribution in tumors and organs from 2D planar scintigraphic data. The systems and methods may introduce an envelope of the 10-norm approximate sparsity metric for planar image reconstruction. The systems and methods may apply an innovative, efficient preconditioned fixed-point algorithm for solving the env-10 model.
The recent remarkable success of AER in the treatment of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617 and other cancers has revealed the striking clinical potential of TAT. However, current methods of imaging the biodistribution of AER are sub-optimal due to very low administered activity (˜100 kBq/kg) resulting in low-count (very noisy) data necessitating planar scintigraphic imaging rather than SPECT. The SOC methods for processing the low-count planar imaging data cannot provide accurate information on AER and hence, on absorbed dose to organs/tumor. Also, the correspondence between AER biodistributions and those of potential imaging surrogates is unknown, compromising the ability to anticipate normal tissue toxicity and prescribe personalized treatment. To remedy this problem, a method for accurate quantitative imaging of the AER biodistribution is needed.
In various embodiments, sparsity promoting regularization can be used to control noise via the novel env-10 norm sparsity metric. In a low-count/high-noise AER, imaging regularization plays two roles: it reduces the ill-posedness of the problem and denoises the images. Ill-posedness is reduced by constraining the solution space. Noise reduction is achieved by using a transform to concentrate the image's meaningful information (energy) on only a few of its components. Noise contamination remains evenly spread out with small magnitude values that can be removed by a threshold, resulting in high accuracy with much less noise. To amplify the denoising performance of the systems/methods, a specially designed TF can be applied, based on a redundant multiscale discrete cosine transform and the env-10 norm, which behaves like the 11-norm near the origin and like the 10-norm elsewhere, as a tractable approximation of the 10-norm due to its continuity despite its nonconvexity. The env-10 norm has the added advantage that it can be unbiased, unlike the 11-norm that removes energy from the signal. The resulting non-smooth, non-convex minimization problem can be formulated as a fixed-point equation and iteratively solved.
The systems and methods discussed herein can include an energy dependent physical model of a gamma imaging SPECT/CT system with high-energy collimators. Photon transport through the collimator can also model septal penetration. Scatter may be estimated via a Monte Carlo kernel and/or scatter window fitting. Scintillation light and/or spatial resolution loss in the NaI (TI) crystal may be modeled. In certain embodiments, a fixed-point formulation of the TF-L0 model can be applied for fast convergence. The validated power-law model can be used to automate regularization weight selection specific to each patient and the administered activity. The regularization optimization procedure may be iterative.
It is noted that, in various embodiments, the functions performed by the systems, devices, and components depicted in, for example,
The embodiments described herein have been described with reference to drawings. The drawings illustrate certain details of specific embodiments that provide the systems, methods and programs described herein. However, describing the embodiments with drawings should not be construed as imposing on the disclosure any limitations that may be present in the drawings.
It is noted that terms such as “approximately,” “substantially,” “about,” or the like may be construed, in various embodiments, to allow for insubstantial or otherwise acceptable deviations from specific values. In various embodiments, deviations of 20 percent may be considered insubstantial deviations, while in certain embodiments, deviations of 15 percent may be considered insubstantial deviations, and in other embodiments, deviations of 10 percent may be considered insubstantial deviations, and in some embodiments, deviations of 5 percent may be considered insubstantial deviations. In various embodiments, deviations may be acceptable when they achieve the intended results or advantages, or are otherwise consistent with the spirit or nature of the embodiments.
It should be noted that although the diagrams herein may show a specific order and composition of method steps, it is understood that the order of these steps may differ from what is depicted. For example, two or more steps may be performed concurrently or with partial concurrence. Also, some method steps that are performed as discrete steps may be combined, steps being performed as a combined step may be separated into discrete steps, the sequence of certain processes may be reversed or otherwise varied, and the nature or number of discrete processes may be altered or varied. The order or sequence of any element or apparatus may be varied or substituted according to alternative embodiments. Accordingly, all such modifications are intended to be included within the scope of the present disclosure as defined in the claims. Such variations will depend on the machine-readable media and hardware systems chosen and on designer choice. It is understood that all such variations are within the scope of the disclosure. Likewise, software and web implementations of the present disclosure may be accomplished with standard programming techniques with rule based logic and other logic to accomplish the various database searching steps, correlation steps, comparison steps and decision steps.
The foregoing description of embodiments has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the disclosure to the precise form disclosed, and modifications and variations are possible in light of the above teachings or may be acquired from this disclosure. The embodiments were chosen and described in order to explain the principals of the disclosure and its practical application to enable one skilled in the art to utilize the various embodiments and with various modifications as are suited to the particular use contemplated. Other substitutions, modifications, changes and omissions may be made in the design, operating conditions and arrangement of the embodiments without departing from the scope of the present disclosure as expressed in the appended claims.
This application claims priority to U.S. Provisional Patent Application No. 63/276,504 filed Nov. 5, 2021, the entirety of which is incorporated herein by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2022/049034 | 11/4/2022 | WO |
Number | Date | Country | |
---|---|---|---|
63276504 | Nov 2021 | US |